Crinetics Pharmaceuticals Inc
CRNX
ISIN null / Valor 42455144
Crinetics Pharmaceuticals Inc
UMushroom community rating:
About company
Crinetics Pharmaceuticals Inc. is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Leveraging its expertise in endocrine pharmacology, the company aims to address unmet medical needs by developing small molecule drugs that target specific hormonal pathways. Crinetics' lead product candidates include paltusotine, an oral nonpeptide somatostatin receptor agonist for the treatment of acromegaly and neuroendocrine tumors, and CRN04894, an oral nonpeptide ACTH antagonist for the treatment of Cushing's disease and congenital adrenal hyperplasia. The company is headquartered in San Diego, California, and actively collaborates with various research and entrepreneurial organizations to foster innovation in the biotech sector.
Summarized from source with an LLMView SourceSector: TechnologyKey figures
Performance
Volatility
5046 M
Market cap (USD)
1,222,459
Daily traded volume (Shares)
51.2 / 50.5
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
